CAPR - Capricor Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CAPR is currently covered by 5 analysts with an average price target of $25.17. This is a potential upside of $17.49 (227.73%) from yesterday's end of day stock price of $7.68.

Capricor Therapeutics's activity chart (see below) currently has 13 price targets and 37 ratings on display. The stock rating distribution of CAPR is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 59% with an average time for these price targets to be met of 535 days.

Highest price target for CAPR is $30, Lowest price target is $22, average price target is $25.2.

Most recent stock forecast was given by JOSEPH PANTGINIS from HC WAINWRIGHT on 11-Jul-2025. First documented stock forecast 15-Sep-2017.

Best performing analysts who are covering CAPR - Capricor Therapeutics:

Joseph Pantginis Leland Gershell Jason Mccarthy Kristen Kluska Aydin Huseynov

Currently out of the existing stock ratings of CAPR, 27 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$24

$15.82 (193.40%)

$77

24 days ago
(11-Jul-2025)

6/15 (40%)

$16.36 (214.14%)

956

Buy

$22

$13.82 (168.95%)

$15

1 months 12 days ago
(23-Jun-2025)

3/4 (75%)

$14.32 (186.46%)

52

Buy

$30

$21.82 (266.75%)

$30

2 months 21 days ago
(14-May-2025)

3/6 (50%)

$22.33 (291.13%)

134

Buy

$25

$16.82 (205.62%)

$12

10 months 10 days ago
(25-Sep-2024)

4/5 (80%)

$14.66 (141.78%)

828

Buy

$25

$16.82 (205.62%)

$15

1 years 2 months 21 days ago
(14-May-2024)

1/2 (50%)

$19.8 (380.77%)

705

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CAPR (Capricor Therapeutics) average time for price targets to be met?

On average it took 535 days on average for the stock forecasts to be realized with a an average price target met ratio 59

Which analyst has the current highest performing score on CAPR (Capricor Therapeutics) with a proven track record?

JOSEPH PANTGINIS

Which analyst has the current lower performing score on CAPR (Capricor Therapeutics) with a proven track record?

AYDIN HUSEYNOV

Which analyst has the most public recommendations on CAPR (Capricor Therapeutics)?

Joseph Pantginis has 32 price targets and 25 ratings on CAPR

Which analyst is the currently most bullish on CAPR (Capricor Therapeutics)?

Kristen Kluska with highest potential upside - $21.82

Which analyst is the currently most reserved on CAPR (Capricor Therapeutics)?

Leland Gershell with lowest potential downside - $13.82

Capricor Therapeutics in the News

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Capricor Therapeutics

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Capricor To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in Capricor between October 9, 2024 and July 10, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi...

ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – CAPR

NEW YORK, July 31, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Capricor Therapeutics, Inc. (NASDAQ: CAPR) between October 9, 2024 and July 10, 2025, both dates inclusive (the “Class Period”), of the important September 15, 2025 lead plaintiff deadline. SO WHAT: If you...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?